Literature DB >> 11175391

Anxiolytic profile of GR 38032F in the potentiated startle paradigm.

B. Glenn1, S. Green.   

Abstract

The potentiated startle paradigm has been demonstrated to be a model of anxiety sensitive to a range of established and putative anxiolytics. This study reports a preliminary investigation of the effects of the 5-HT(3) antagonist GR 38032F on potentiated startle. Doses of 0.01 and 0.1mg/kg each showed an anxiolytic profile in significantly reducing startle amplitude, with the lower dose having an effect comparable to chlordiazepoxide at 5.0mg/kg. 5-hydroxytryptophan at 25mg/kg significantly enhanced startle amplitude, and a mutual antagonism was found when 5-HTP was combined with GR 38032F. The results extend previous work with other models of anxiety suggesting anxiolytic potential for GR 38032F, and further demonstrate the possibility that the anxiolytic effect is mediated by serotonergic mechanisms.

Entities:  

Year:  1989        PMID: 11175391     DOI: 10.1097/00008877-198900110-00011

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  4 in total

1.  Blockade of the discriminative stimulus effects of ethanol with 5-HT3 receptor antagonists.

Authors:  K A Grant; J E Barrett
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  The selective 5-HT3 receptor antagonist, WAY100289, enhances spatial memory in rats with ibotenate lesions of the forebrain cholinergic projection system.

Authors:  H Hodges; P Sowinski; J D Sinden; C A Netto; A Fletcher
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

Review 3.  5-HT receptors as targets for the development of novel anxiolytic drugs: models, mechanisms and future directions.

Authors:  J E Barrett; K E Vanover
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

4.  Profile of action of 5-HT3 receptor antagonists, ondansetron and WAY 100289, in the elevated plus-maze test of anxiety of mice.

Authors:  R J Rodgers; J C Cole; J M Tredwell
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.